Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Dallio

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|April 21, 2020
Inflammatory Bowel Diseases: The Role of Gut MicrobiotaCristiana De Musis, Lucia Granata, Marcello Dallio, et al.
Reviews on Recent Clinical Trials|August 13, 2016
Epidemiology and Natural History of Alcoholic Liver DiseaseMario Masarone, Valerio Rosato, Marcello Dallio, et al.
Nutrients|April 30, 2021
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New InsightsAlessandro Federico, Valerio Rosato, Mario Masarone, et al.
Reviews on Recent Clinical Trials|July 27, 2016
Alcoholic Hepatitis: Pathogenesis, Diagnosis and TreatmentLudovico Abenavoli, Mario Masarone, Alessandro Federico, et al.
Reviews on Recent Clinical Trials|January 28, 2016
Alcoholic Liver Disease and Hepatitis C Chronic InfectionAlessandro Federico, Marcello Dallio, Vittorio M Ormando, et al.
International Journal of Environmental Research and Public Health|August 24, 2019
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean WayLudovico Abenavoli, Luigi Boccuto, Alessandro Federico, et al.
Nutrients|April 2, 2020
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up ObservationAntonietta Gerarda Gravina, Marcello Dallio, Mario Romeo, et al.
Diseases (Basel, Switzerland)|April 26, 2024
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver DiseaseGiuseppe Guido Maria Scarlata, Carmen Colaci, Marialaura Scarcella, et al.
World Journal of Gastroenterology|December 11, 2014
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver diseaseAlessandro Federico, Claudio Zulli, Ilario de Sio, et al.
Frontiers in Medicine|October 25, 2021
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled TrialMarcello Dallio, Mario Masarone, Mario Romeo, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|April 21, 2020
Inflammatory Bowel Diseases: The Role of Gut MicrobiotaCristiana De Musis, Lucia Granata, Marcello Dallio, et al.
Reviews on Recent Clinical Trials|August 13, 2016
Epidemiology and Natural History of Alcoholic Liver DiseaseMario Masarone, Valerio Rosato, Marcello Dallio, et al.
Nutrients|April 30, 2021
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New InsightsAlessandro Federico, Valerio Rosato, Mario Masarone, et al.
Reviews on Recent Clinical Trials|July 27, 2016
Alcoholic Hepatitis: Pathogenesis, Diagnosis and TreatmentLudovico Abenavoli, Mario Masarone, Alessandro Federico, et al.
Reviews on Recent Clinical Trials|January 28, 2016
Alcoholic Liver Disease and Hepatitis C Chronic InfectionAlessandro Federico, Marcello Dallio, Vittorio M Ormando, et al.
International Journal of Environmental Research and Public Health|August 24, 2019
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean WayLudovico Abenavoli, Luigi Boccuto, Alessandro Federico, et al.
Nutrients|April 2, 2020
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up ObservationAntonietta Gerarda Gravina, Marcello Dallio, Mario Romeo, et al.
Diseases (Basel, Switzerland)|April 26, 2024
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver DiseaseGiuseppe Guido Maria Scarlata, Carmen Colaci, Marialaura Scarcella, et al.
World Journal of Gastroenterology|December 11, 2014
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver diseaseAlessandro Federico, Claudio Zulli, Ilario de Sio, et al.
Frontiers in Medicine|October 25, 2021
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled TrialMarcello Dallio, Mario Masarone, Mario Romeo, et al.
Pageof 10